Article: MultiVu Video Feed: FDA Approves Pfizer's CHANTIX(TM) (varenicline) for Smoking Cessation.

First Prescription Medication Approved for Smoking Cessation in Almost a Decade

Trial Results Showed People Had Four Times Greater Odds of Quitting With CHANTIX (1 mg twice daily) vs Placebo and Two Times Greater Odds Versus Zyban(R) (150 mg twice daily)

NEW YORK, May 11 /PRNewswire/ -- The U.S. Food and Drug Administration (FDA) has approved Pfizer's anti-smoking pill CHANTIX. CHANTIX, the first prescription medication approved in almost a decade for smoking cessation, received priority review by the FDA because of its potential to be a significant therapeutic advance over existing therapies.

 
  WHY IT'S IMPORTANT: 
 
  * The U.S. Centers for ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!